Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: J Pain. 2019 Nov 21;21(7-8):798–807. doi: 10.1016/j.jpain.2019.11.007

Table 3.

Means (SD) for Primary and Secondary Measures for All Completers (n = 22)

Group Baseline Follow-up Cohen’s d for Integrated vs Usual Care at Follow-up
Current opioid misuse
Integrated intervention 16.2 (8.8) 10.6 (6.5) 0.73
Usual care 17.4 (7.8) 16.1 (8.5)
Pain interference
Integrated intervention 66.7 (6.6) 64.3 (9.2) 0.79
Usual care 65.2 (6.8) 70.1 (4.9)
Pain behavior
Integrated intervention 66.7 (6.6) 64.3 (9.2) 0.30
Usual care 66.0 (6.6) 66.8 (8.0)
Pain intensity
Integrated intervention 6.6 (1.5) 5.6 (1.9) 1.08
Usual care 6.7 (1.8) 7.4 (1.4)
Prescribed opioid dose
Integrated intervention 96.4 (70.1) 91.3 (72.1) 0.83
Usual Care 51.8 (45.6) 41.6 (43.1)

Measures: Current opioid misuse: Current Opioid Misuse Measure, Pain interference: PROMIS Pain Interference short form 8a; Pain behavior: PROMIS Pain Behavior v1.1 short form 7a; Pain intensity: 0 to 10 numerical rating scale of average pain for past week; Prescribed opioid dose: Morphine Equivalent Dose for all prescribed opioids.